Anti-proliferative activity of a new class of taxanes (14β-hydroxy-10- deacetylbaccatin III derivatives) on multidrug-resistance-positive human cancer cells

International Journal of Cancer

Volumn 72, Issue 5, 1997, Pages 844-850

  Distefano, Mariagrazia ^a   Scambia, Giovanni ^a   Ferlini, Cristiano ^a   Gaggini, Cristiana ^a   De Vincenzo, Rosa ^a   Riva, Antonella ^b   Bombardelli, Ezio ^b   Ojima, Iwao ^c   Fattorossi, Andrea ^a   Panici, Pierluigi Benedetti ^a   Mancuso, Salvatore ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b INDENA S P A   (Italy)

^c STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACCATIN III; DEACETYLBACCATIN III DERIVATIVE; DOCETAXEL; IDN 5102; IDN 5106; IDN 5108; IDN 5111; IDN 5127; ORTATAXEL; PACLITAXEL; PACLITAXEL DERIVATIVE; TAXANE DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL CYCLE; CELL STRAIN MCF 7; CONTROLLED STUDY; HUMAN; HUMAN CELL; LEUKEMIA CELL; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BREAST NEOPLASMS; CELL CYCLE; CELL DIVISION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, MULTIPLE; FEMALE; HUMANS; LEUKEMIA; MITOSIS; PACLITAXEL; STRUCTURE-ACTIVITY RELATIONSHIP; TAXOIDS; TRITERPENES; TUMOR CELLS, CULTURED;

EID: 15444349941     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970904)72:5<844::AID-IJC22>3.0.CO;2-7     Document Type: Article

References (24)

1. APPENDINO, G., GARIBOLDI, P., GABETTA, B., PACE, R., BOMBARDELLI, E. and VITERBO, D., 14Beta-hydroxy-10-deacetyl-baccatin III, a new taxane from Himalayan yew (Taxus wallichiana Zucc.). J. chem. Soc. Perkin Trans., 1, 2925-2929 (1992).
2. BISSERY, M.C., GUÉNARD, D., GUÉRETFE-VOLGELEIN, F. and LAVELLE, F., Experimental antitumor activity of taxotere (RP569F6, NSC628503), a taxol analogue. Cancer Res., 51, 4845-4852 (1991).
3. DARZYNKIEWICZ, Z., BRUNO, S., DEL BINO, G., GORCZYCA, W., HOTZ, M.A., LASSOTA, P. and TRAGANOS, F., Features of apoptotic cells measured by flow cytometry. Cytometry, 13, 795-808 (1992).
4. FERLINI, C., DI CESARE, S., RAINALDI, G., MALORNI, W., SAMOGGIA, P., BISELLI, R. and FATTOROSSI, A., A flow cytometric analysis of the early phases of apoptosis by cellular and nuclear techniques. Cytometry, 24, 106-115 (1996).
5. FERLINI, C., SCAMBIA, G., DISTEFANO, M., FILIPPINI, P., ISOLA, G., RIVA, A., BOMBARDELLI, E., FATTOROSSI, A., BENEDETTI PANICI, P. and MANCUSO, M., Synergistic antiproliferative activity of tamoxifen and docetaxel on three estrogen receptor negative cancer cell lines is mediated by induction of apoptosis. Brit. J. Cancer, 75, 884-891 (1997).
6. FUMOLEAU, P., CHEVALLIER, B., KERBRAT, P., DIERAS, V., AZLI, N., BAYSSAS, M. and VON GLOBBEKE, M., Current status of taxotere (docetaxel) as a new treatment in breast cancer. Breast Cancer Res. Treat., 33, 39-46 (1994).
7. GRECO, A., STROUP, S.L., GRAY, J.R. and HAINSWORTH, J.D., Paclitaxel in combination chemotherapy with radiotherapy in patients with unresectable stage III non-small-cell lung cancer. J. clin. Oncol., 14, 1642-1648 (1996).
8. HORWITZ, S.B., LOTHSTEIN, L., MANFREDI, J.J., MELLADO, W., PARNESS, J., ROY, S.N., SCHIFF, P.B., SORBARA, L. and ZEHEB, R., Taxol: mechanisms of action and resistance. Ann. N.Y. Acad. Sci., 466, 733-744 (1986).
9. HUDIS, C.A. and 14 OTHERS, Phase II and pharmacologic study of docetaxel as initial chemotherapy for metastatic breast cancer. J. clin. Oncol., 14, 5865-5868 (1996).
10. IRELAND, C.M. and PITTMAN, S.M., Tubulin alterations in taxol-induced apoptosis parallel those observed with other drugs. Biochem. Pharmacol., 49, 1491-1499 (1995).
11. JORDAN, M.A., TOSO, R.J., THROWER, D. and WILSON, L., Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations. Proc. nat. Acad. Sci. (Wash.), 90, 9552-9556 (1993).
12. KLEIN, L.L., LI, L., MARING, C.J., YEUNG, C.M., THOMAS, S.A., GRAMPOVNIK, D.J. and PLATTNER, J.J., Antitumor activity of 9(R)-dihydrotaxane analogs. J. biol. Chem., 38, 1482-1492 (1995).
13. LIEBMANN, J.E., COOK, J.A., LIPSCHULTZ, C., TEAGUE, D., FISHER, J. and MITCHELL, J.B., Cytotoxic studies of paclitaxel (taxol) in human tumor cell lines. Brit. J. Cancer, 68, 1104-1109 (1993).
14. MCGUIRE, W.P., HOSKINS, W.J., BRADY, M.F., KUCERA, P.R., PARTRIDGE, E.E., LOOK, K. Y., CLARKE-PEARSON, D.L. and DAVIDSON, M., Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N. Engl. J. Med., 334, 1-6 (1996).
15. MCGUIRE, W.P., ROWINSKY, E.K., ROSENSHEIN, N.B., GRUMBINE, F.C., ETTINGER, D.S., ARMSTRONG, D.K. and DONEHOWER, R.C., Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms. Ann. Intern. Med., 111, 273-279 (1989).
16. NYGREN, P. and 14 OTHERS, The cytotoxic activity of taxol in primary cultures of tumor cells from patients is partly mediated by Cremophor EL. Brit. J. Cancer, 71, 478-481 (1995).
17. O'SHAUGHNESSY, J.A. and COWAN, K.H., Current status of paclitaxel in the treatment of breast cancer. Breast Cancer Res. Treat., 33, 27-37 (1994).
18. RINGEL, I. and HORWITZ, S.B., Studies with RP56976 (taxotere): a semisynthetic analogue of taxol. J. nat. Cancer Inst., 83, 288-291 (1991).
19. ROWINSKY, E.K., CAZENAVE, L.A. and DONEHOWER, R.C., Taxol: a novel investigational antimicrotubule agent. J. nat. Cancer Inst., 82, 1247-1259 (1990).
20. SCAMBIA, G., RANELLETTI, F.O., BENEDETTI PANICI, P., DE VINCENZO, R., BONANNO, G., FERRANDINA, G., PIANTELLI, M., BUSSA, S., RUMI, C., CIANFRIGLIA, P. and MANCUSO, S., Quercetin potentiates the effect of Adriamycin in a multidrug resistant MCF-7 human breast cancer cell line: P-glycoprotein as a possible target. Cancer Chemother. Pharmacol., 94, 459-464 (1994).
21. SEIDMAN, A.D. and 16 OTHERS, Paclitaxel as second and subsequent therapy for metastatic breast cancer: activity independent of prior anthracyclin response. J. clin. Oncol., 13, 1152-1159 (1995).
22. SLICHENMYER, W.J. and VON HOLFF, D.D., Taxol: a new and effective anticancer drug. Anticancer Drugs, 2, 519-530 (1991).
23. SWINDELL, C.S., KRAUSS, N.E., HORWITZ, S.B. and RINGEL, I., Biologically active taxol analogues with deleted A-ring side chain substituents and variable C-2′ configurations. J biol. Chem., 34, 1176-1184 (1991).
24. WANI, M.C., TAYLOR, H.L., WALL, M.E., COGGON, P. and MCPHAIL, A.T., Plant antitumor agents. VI Isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J. Amer. chem. Soc., 93, 2325-2327 (1971).